MedTrace Logo

Scanadu Consumer Health Outcomes (SCOUT) Study

NCT02134145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2018-02-28

No results posted yet for this study

Summary

There is a great need within healthcare to develop systems of care that better engage and activate people in their own care before they become patients. By so doing lay users will be empowered to take charge of their own care in recognizing they can change their health and improve their quality of life. Mobile health technologies such as the Scanadu ScoutTM hold the potential to truly engage individuals in the way needed through real-time data capture, transmission and connectivity.

We propose to evaluate the real-world use of the Scanadu ScoutTM by a cohort of self-selected investors in an earlier crowdfunding campaign on Indiegogo for the Scanadu Scout™, through a prospective observational study. Using validated survey tools and through the remote tracking of frequency of use and physiological measurements from the Scanadu Scout™ device and app.

Participants will receive web-based surveys at 4 time points: baseline, 3, 12 and 18 months.

Participants will be instructed to use the Scanadu Scout™ as much as they would like. The parameters that will be functional on the device and available for measurement by the participant are:

* Heart rate
* Respiratory rate
* Temperature
* Oxygen saturation
* Heart rate variability
* Blood pressure

Data analysis will examine individual participant and aggregate level:

1. Usage and physiologic measurement data of the device,
2. Perceptions of the device, and
3. Changes in self-reported health self-management, health-related quality of life, participant- physician communication and medication adherence between baseline and follow-up.

Conditions

  • Disorder Characterized by Fever

Sponsors & Collaborators

  • Scanadu, Inc.

    collaborator INDUSTRY

  • Scripps Translational Science Institute

    lead OTHER

Principal Investigators

  • Steven Steinhubl, MD · STSI

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-11-30
Completion
2018-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02134145 on ClinicalTrials.gov